Allspring Global Investments’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
Other funds holding RDY
AIM
Allspring Global Investments's RDY Position: Q2 2025 in Review
Allspring Global Investments sold out of Dr. Reddy's Laboratories (RDY) in Q2 2025, closing a stake of 94,682 shares — an estimated $1.25M sold.
Allspring Global Investments first reported a position in RDY in Q4 2021 and held it in 14 quarters. The position peaked at $8.48M in Q3 2024. 243 funds tracked by Wall St. Rank hold RDY as of Q2 2025.
- Allspring Global Investments reported no remaining Dr. Reddy's Laboratories position as of Q2 2025 after selling out during the quarter.
- Allspring Global Investments sold 94,682 Dr. Reddy's Laboratories shares in Q2 2025, an estimated $1.25M.
- Allspring Global Investments first reported a position in Dr. Reddy's Laboratories in Q4 2021 and held it in 14 quarters.
- Allspring Global Investments's Dr. Reddy's Laboratories position peaked at $8.48M in Q3 2024.
- 243 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2025.
Based on Allspring Global Investments's 13F filing for Q2 2025, filed 25 Jul 2025.